Knocking out Irf3, Irf7, Gsdme or Ripk3 in B16F10 tumor cells each reduced DAC’s effectiveness at inducing immune control of the tumor, which indicates that the derepression of multiple innate immune pathways helped to restore immune control (Zhang et al, 2024). The gene discussed is RIPK3; the disease is neoplasm.